Hank McKinnell
Hank McKinnell
Henry A. McKinnell, Jr.is the former chief executive officer and former chairman of the board of directors of Pfizer Inc. He is also a director of ExxonMobil and Moody's...
believe ceos challenges despite economy remain resilient several
Going into 2006, America's CEOs believe that the economy will remain resilient despite the challenges of several unanticipated events.
access help medicines providing simplicity
We are providing choice, simplicity and expanded access to help Americans get the medicines they need,
consistent court decision encourage exist laws lower medical millions patent patients principle support undermine
Lipitor is one of the most important medical breakthroughs of our era, and millions of patients have used it to lower their cholesterol. This court decision is consistent with the fundamental principle that patent laws exist to support and encourage medical innovators, not undermine them.
coming difficult easy estimate fourth fully last quarter second share soon sure understand year
What analysts are coming to understand is that comparisons to last year are particularly difficult in the second quarter, ... And what I am sure they will soon understand is that comparisons are particularly easy in the fourth quarter and that makes our estimate of $1.56 to $1.60 (per share for 2002) fully achievable.
add additional business confidence fill increasing jobs opposed payroll people permanent point seeing trying willing
You are seeing business confidence increasing to the point where people are willing to add permanent jobs to the payroll as opposed to trying to fill that need through additional overtime.
actions build driving key medicines newly pipeline series specific supporting taking
We are supporting our key in-line and newly launched medicines, driving important new medicines through the pipeline and taking a series of specific actions to build Pfizer's value.
directed estimates increase last low percentage putting quarter unusually year
They had been putting the same percentage increase on each quarter, and in an unusually low quarter like last year that didn't' work, ... So we directed them to take down their second-quarter estimates through our guidance.
confidence last normal planning week
This is a normal part of our planning cycle, ... You should have as much confidence in us this week as you had last week.
build directly environment investing operating realities responding time today value
This is a time of transformation for Pfizer and our industry. We are responding directly to the realities of our operating environment as we build value today while aggressively investing in the future.
consistent court decision encourage exist laws medical patent principle support undermine
This court decision is consistent with the fundamental principle that patent laws exist to support and encourage medical innovators, not undermine them,
dramatic looks lowering maybe raising risk
It looks like a combination of raising HDL and lowering LDL cholesterol could have dramatic impact, maybe eliminating cardiovascular risk,
close zero
as close to zero as you can get.
companies pipeline quite together
Quite frankly, with the two companies together we can get more out of the pipeline than we could separately.
looks quit rate
Our drug looks like it can take the quit rate up to 50 percent,